Advances in Pharmacoepidemiology and Drug Safety

Current Issue

Volume 10, Issue 2, 2021

Research Article

Comparison among Reference, Generic and Similar Drugs from the Same Active Substance

• Suzana O. Santos*, Vivianne L. B de Souza, Romiton dos S. Amaral

Review Article

Emergence of 3D Printed Dosage Forms: A Focus on FDM 3D Printing and Multi-Material Printing

• M A Alhnan*

Review Article

Quantification of 3α-Acetyl-11-Keto-β-Boswellic Acid and 11-Keto-β-Boswellic Acid in the Resin of Boswellia species by HPTLC

• Sisay Awoke*

Review

Antibody Drug Conjugates (ADC)-The Current Status

• Andrew Zelar*

Editorial

Editorial Note on Drug Safety

• Mustafa Sevindik

Volume 10, Issue 4, 2021

Commentary

A nonamer is what the protoribosome can do

• Yuhong Wang*

Short Communication

FBS vs. ACM: How should Human Cells be Cultured?

• Yao Tang*

Volume 10, Issue 5, 2021

Research Article

Prevalence and Safety of Prescription Medicine Use During Pregnancy in the Republic of Suriname in the Year 2017: A Pharmacoepidemiological Analysis

• Vinoj H. Sewberath Misser*, Arti Shankar, Ashna Hindori-Mohangoo, Jeffrey Wickliffe, Maureen Lichtveld and Dennis R.A. Mans*

Research Article

Duration of Antidepressant Use and Risk of New Onset Drug Treated Diabetes Derived from Australian Administrative Data

• Shaun Francis Purkiss*

Research Article

Post-Marketing Change in Dosage and Administrations of FDA-Approved Drugs Between 2000 and 2017

• Masako Ashida* and Mamoru Narukawa

Editorial

Nanoparticles for Drug Delivery

• Andrew Zelar*

Research Article

Review on Phytochemical Studies of Ethiopian Medicinal Plants from 1970's-2020, and their Potential as Source of Modern Drugs

• Tewodros Mulu

Volume 11, Issue 6, 2022

Perspective

Types of Drug Interactions and their Uses

• Robert M Straubinger*

DOI: 10.35248/2167-1052.22.11.283

Commentary

Different Phases of Clinical Trails: Design and Classification

• Stefanie Henni*

DOI: 10.35248/2167-1052.22.11.284

Opinion Article

Estimation and Determination of Vitamins by Using Drugs

• Hester Visser*

DOI: 10.35248/2167-1052.22.11.285

Short Communication

Drug Allergy: Symptoms and Treatment

• Shigeki Matsunaga*

DOI: 10.35248/2167-1052.22.11.286

Abstract

Drug Importance in Healthcare and Applications

• Qiliang Tan*

DOI: 10.35248/2167-1052.22.11.287

Volume 13, Issue 1, 2024

Commentary

Resolving Drug Utilization Patterns: Role of Big Data in Pharmacoepidemiology

• Alberto Kava*

DOI: 10.35248/ 2167-1052.23.13.344

Perspective

Exploring the Potential of Ultrasound in Precision Drug Delivery

• Mark Lee*

DOI: 10.35248/ 2167-1052.23.13.345

Opinion Article

Technology-Driven Safety Strategies: Enhancing Food and Drug Security

• Amanda Quick*

DOI: 10.35248/ 2167-1052.23.13.346

Short Communication

Drug-Eluting Stent Thrombosis: From Incidence to Preventive Strategies

• Kenji Arata*

DOI: 10.35248/ 2167-1052.23.13.347

Commentary

A Structured Approach: The 3-Step Algorithm for Type 2 Disease Diagnosis and Biologic Therapy Selection

• Daisuke Fuji*

DOI: 10.35248/ 2167-1052.23.13.348

Perspective

Developing Healthcare: Collaboration among Regulations, HTA, and Drug Safety Assessments

• Andrej Zivor*

DOI: 10.35248/ 2167-1052.23.13.349

Opinion Article

Pharmacological Insights: Aripiprazole's Role and Drug Safety in Bipolar Disorder

• Wang Chen*

DOI: 10.35248/ 2167-1052.23.13.350

Commentary

Structural Genomics Analysis: Exposing SARS-CoV-2 and Omicron Variants for Drug Development

• Hikari Naomi*

DOI: 10.35248/ 2167-1052.23.13.351

Perspective

Managing Myelosuppression: Strategies for Optimal Care in Transplant Patients

• Catherine Cole*

DOI: 10.35248/ 2167-1052.23.13.352

Opinion Article

Advancements in Treatment: Breaking Down HIV/HCV Coinfection Barriers

• Rosalind Wade*

DOI: 10.35248/ 2167-1052.23.13.353

Volume 13, Issue 3, 2024

Short Communication

Evaluating Drug Safety and Effectiveness in Cancer Pharmacoepidemiology

• Wang Sun*

DOI: 10.35250/2167-1052.24.13.364

Perspective

The Future of Pharmacoepidemiology: Transforming Drug Safety through Technology and AI

• Rodrigo Xia*

DOI: 10.35250/2167-1052.24.13.365

Perspective

The Phases of Clinical Pharmacological Trials: Ensuring Safety, Efficacy and Public Health

• Emma Wang*

DOI: 10.35250/2167-1052.24.13.366

Perspective

Herbal Medicine: Combining Nature's Remedies for Modern Health

• Xiao Qiao*

DOI: 10.35250/2167-1052.24.13.367

Opinion Article

Empowering Patient Care through Pharmacotherapy: Strategies and Insights

• Yuca Guo*

DOI: 10.35250/2167-1052.24.13.368

Opinion Article

Modulating Oxidative Stress: The Role of Pharmacological Agents in Redox Homeostasis

• Cuihong Shouchao*

DOI: 10.35250/2167-1052.24.13.369

Opinion Article

The Cycle of Drug Dependency: Physiological Adaptation and Social Strain

• Fontana Emiliano*

DOI: 10.35250/2167-1052.24.13.370

Commentary

The Intersection of Genetics and Drug Response: Advancing Personalized Medicine

• Yang Lin*

DOI: 10.35250/2167-1052.24.13.371

Commentary

Thrombosis and Blood Clots: Understanding the Risks and Remedies

• Zhang Yue*

DOI: 10.35250/2167-1052.24.13.372

Commentary

Ellipticine: Mechanisms of Action and Future Directions in Cancer Therapy

• Wang Zhu*

DOI: 10.35250/2167-1052.24.13.373

Volume 14, Issue 1, 2025

Commentary

Modern Approaches to Drug Hypersensitivity Diagnosis

• Serena Takahashi*

DOI: 10.35250/2167-1052.25.14.379

Opinion Article

Pregnancy and Pharmacotherapy toward Safer Individualized Treatment Decisions

• Alessandra Ruiz-Gonzalez*

DOI: 10.35250/2167-1052.25.14.380

Perspective

Overcoming Resistance in Multiple Myeloma with Nanomedicine

• Thomas J. Wainwright*

DOI: 10.35250/2167-1052.25.14.381

Short Communication

Reflexive Drug Testing Enhances Diagnostic Accuracy and Resource Efficiency

• Lucas van Dijk*

DOI: 10.35250/2167-1052.25.14.382

Commentary

Pharmacoepidemiology Advancing Cardiovascular Research beyond Clinical Trials

• Javier Ortega-Santos*

DOI: 10.35250/2167-1052.25.14.383

Opinion Article

Ultraorphan Drugs and the Challenge of Balancing Innovation with Affordability

• Kenta Mori*

DOI: 10.35250/2167-1052.25.14.384

Perspective

Personalizing Medication to Prevent Adverse Drug Reactions with Pharmacogenomics

• Diego Alvarez-Rojas*

DOI: 10.35250/2167-1052.25.14.385

Commentary

Transforming Disease Targeting with Bio-Orthogonal Chemistry and Glycan Engineering

• Hanae Fujimoto*

DOI: 10.35250/2167-1052.25.14.386

Opinion Article

Predicting Drug–Drug Interactions Using Multimodal Graph Representations

• Rafael Moretti*

DOI: 7 10.35250/2167-1052.25.14.387

Perspective

Identifying Drug-Related Respiratory Adverse Events in Sleep Apnoea

• Isabelle Tremblay*

DOI: 10.35250/2167-1052.25.14.388

Volume 13, Issue 4, 2024

Research Article

Four Chromosomally Clustered Amph Class-C β-Lactamases Control the Cephalosporin Hydrolysis in Mycobacterium tuberculosis and Similar Genetic Loci Appeared as Pseudogenes in Mycobacterium leprae

• Asit Kumar Chakraborty*

DOI: 10.35250/2167-1052.24.13.374

Commentary

Adverse Drug Reactions: Understanding Their Impact and Management

• Jane Kelley*

DOI: 10.35250/2167-1052.24.13.375

Commentry

Precision Medicine through Advanced Drug Delivery Systems

• Yan Ling*

DOI: 10.35250/2167-1052.24.13.376

Opinion Article

Epidemiology of Drugs: Impact of Drug Use on Public Health

• Elise Camilla*

DOI: 10.35250/2167-1052.24.13.377

Perspective

Drug Safety Surveillance: Importance, Mechanisms and Strategies

• Kenzo Yoshi*

DOI: 10.35250/2167-1052.24.13.378